Cryoport receives 2023 imapac asia pacific cell & gene therapy excellence award

Company named "best cell & gene therapy supplier – cryogenic storage" nashville, tenn. , sept. 14, 2023 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or the "company"), a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, today announced that the company has been named "best cell & gene therapy supplier – cryogenic storage" as part of this year's imapac asia pacific cell & gene therapy excellence awards.
CYRX Ratings Summary
CYRX Quant Ranking